Influence of alcohol and illicit drug use on the clinical evolution of tuberculosis
DOI:
https://doi.org/10.21727/rpu.v17i1.5523Abstract
Introduction: Infection caused by Mycobacterium tuberculosis stands out as an important cause of death by a single etiological agent, especially among vulnerable populations. Objective: to analyze the influence of alcohol and illicit drug use on the clinical evolution of tuberculosis (TB). Materials and Method: integrative literature review using the PVO method to formulate the question - "What is the influence of alcohol and illicit drug use on the clinical evolution of patients with TB?". The question was prepared based on the Health Science Descriptors (DeCS), Medical Subject Headings (MESH) and Embase Subject Heading (Emtree), which combined using the Boolean operators AND and OR constituted the search expression in the fields by title, abstract and keywords in the PubMed, LILACS, EMBASE, Web of Science and Scopus databases. Full-text articles, primary, in Portuguese, English or Spanish, from 2014 to 2024 were considered. Results: 48 articles were selected for full reading and analysis. Discussion: Most of them addressed the influence of alcohol or illicit drug use on treatment adherence, contributing to loss of follow-up, death from TB, longer culture conversion time, higher percentage of lung involvement and development of antimicrobial resistance, especially among those with Human Immunodeficiency Virus (HIV) or smokers. Final considerations: substance use contributes not only to the perpetuation of the transmission chain, but also to unfavorable outcomes that could be avoided, interfering with the effectiveness of health surveillance actions.
Keywords: Tuberculosis; Alcoholism; Illicit drugs; Treatment Outcome; Epidemiology.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Mariana Bobato Pulgatti, Rafaele Oliveira Bonfim, Rebeca Sousa Braga, Arlindo Gonzaga Branco Junior, Nathalia Halax Orfão

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution License, which allows sharing the work with acknowledgement of authorship and initial publication through this journal.
This license lets others distribute, remix, adapt and create upon your work, even commercially, as long as they credit you for the original creation. It is the most flexible license of all available. It is recommended for maximizing the dissemination and use of the licensed materials.
Authors are permitted to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g. by posting it to an institutional repository or as a chapter in a book), with acknowledgement of the work's authorship and initial publication in this journal.
See the full legal text of the license at: https://creativecommons.org/licenses/by/4.0/









